NURS FPX 8022 Assessment 1 Using Data to Make Evidence-Based Technology Recommendations example

Reviewed by Odette Lachlan, MSN, RN Nursing Technology and Advanced Healthcare Information Systems Capella University Free custom sample in 24 to 48h

This NURS FPX 8022 Assessment 1 sample paper uses data to make evidence-based technology recommendations about intravenous medication errors at a two-hospital system. It was written for Capella NURS FPX 8022, Nursing Technology and Advanced Healthcare Information Systems, a DNP course listed as NURS-FPX8022. The paper starts with the organization's own numbers, examines data quality, and considers the class of technology before any product. It keeps independent evidence separate from vendor material, reports what nurses said, and asks whether technology is the answer at all. Costs, resources and risks of each option, how success would be measured and a recommendation close the paper.

CourseNURS FPX 8022 Nursing Technology and Advanced Healthcare Information Systems
AssessmentAssessment 1
Paper typeTechnology recommendation paper
LengthAbout 1,080 words, 5 pages
FormatAPA 7 student paper
SchoolCapella University
ProgramDNP
UpdatedSeptember 2026

Free sample paper for NURS FPX 8022 Assessment 1

1

Using Data to Make Evidence-Based Technology Recommendations: Intravenous Medication Errors at a Two-Hospital System

Student Name

Capella University

NURS FPX 8022: Nursing Technology and Advanced Healthcare Information Systems

Instructor Name

Month Day, Year

What this part is doingThe title names the problem and the setting and promises a recommendation built from data. Scorers look for recommendations that begin with the organization's evidence, not with a product.
2

Introduction

Technology decisions in health care often begin with a product demonstration. A better approach begins with the organization's own data about a problem and asks what, if anything, technology can do about it. This paper uses data from a two-hospital system to examine intravenous medication errors, evaluates the quality of the data, considers classes of technology, reviews evidence independently of vendor material, and asks whether technology is the right answer.

The Organization's Own Numbers First

Over the past 12 months, the system's event reporting database recorded 214 intravenous medication events, of which 61 reached the patient and 9 caused temporary harm. The most common types were wrong rate (38%), wrong dose (21%), and omission or delay (19%). A direct observation audit of 240 infusions found that 13% had a discrepancy between the pump settings and the order, and that the pump's drug library, intended to catch dosing errors, was bypassed for 22% of infusions. The audit is more informative than the event reports, because it measures errors whether or not anyone noticed or reported them.

Data Quality Examined

The event data have known weaknesses. Event reporting depends on staff noticing and choosing to report, so it undercounts errors and overrepresents those that cause visible harm. Reporting rates vary by unit, which may reflect reporting culture rather than error rates. The observation audit is more reliable but covers only a sample of infusions on six units during day shifts. Together, the data suggest a substantial problem concentrated in rate and dose errors and library bypass, but the true frequency is uncertain.

What this part is doingData quality is assessed before the data are used to justify a recommendation. Scorers reward papers that treat organizational data critically rather than at face value.
3

Class Before Product

Several classes of technology could address intravenous errors: smart pumps with drug libraries, which the system already has; interoperability between the pump and the electronic health record, which sends orders to the pump automatically; barcode scanning at the pump; and clinical decision support in ordering. The data point to a specific class. Most errors occur at the pump, in rate and dose programming, and library bypass is common. Interoperability addresses both, since it removes manual programming and applies the library automatically. Decision support at ordering would not address errors that occur after a correct order is written.

Evidence Separate From Vendor Material

Independent evidence was reviewed separately from vendor claims. A multihospital observational study found that intravenous administration errors were common despite smart pumps, with many related to manual programming and library bypass, supporting the rationale for interoperability (Schnock et al., 2017). Guidance from the Institute for Safe Medication Practices (2020) recommends keeping drug libraries aligned with the concentrations pharmacies actually stock and monitoring library compliance as a routine safety measure. Vendor materials claim reductions of more than 80% in programming errors after interoperability, based on customer case studies that were not independently verified. The recommendation relies on the independent evidence and treats vendor figures as claims to be tested.

What Nurses Said

Interviews with twelve nurses from three units explained the audit findings. Nurses described bypassing the library when the drug they were hanging was not in it, when the concentration differed, or when they were in a hurry during an emergency. Several said they did not trust the library because it had given them incorrect limits in the past. Two described programming the pump from memory for common infusions. These accounts point to library design and workflow as much as to individual choices.

Whether Technology Is the Answer

Before recommending technology, the analysis asked whether non-technical changes would address the problem. Staff interviews found that nurses bypass the library because many drug entries do not match the concentrations stocked by pharmacy, so the library often cannot be used. That is a process problem: pharmacy and nursing could align the library with stocked concentrations without new technology. Library compliance would likely improve, and some errors would be prevented. The honest answer is that part of the problem is not a technology problem at all, and fixing the library should come first whether or not interoperability is purchased.

What this part is doingThe paper asks whether a non-technical fix addresses part of the problem. Scorers reward technology recommendations that consider the full range of solutions.
4

Costs and Resources of Each Option

The options differ in cost. Aligning the drug library requires pharmacist and nurse time, estimated at 200 hours over three months, and no capital. Pump interoperability requires interface licenses from both vendors, informatics build time, network assessment, and training, estimated by the system's finance team at 600,000 to 900,000 dollars over two years, plus ongoing maintenance. Adding barcode scanning at the pump without interoperability would cost less but would not remove manual programming, which the data identify as the main source of error. Presenting the cost of each option side by side lets executives see that the least expensive step also addresses a documented cause of the problem.

Risks of Each Path

Each path carries risk. Fixing the library alone may leave rate errors untouched if nurses continue to program manually. Interoperability depends on reliable wireless coverage and accurate order entry; if orders are incomplete, the pump cannot be programmed automatically and nurses revert to manual entry. Implementation also creates a transition period in which some units use the new workflow and others do not, which can confuse float nurses. These risks argue for the staged approach and a pilot before system-wide adoption.

How Success Would Be Measured

Success will be measured with the same observation audit used at baseline, repeated after each step: library compliance, the rate of pump-order discrepancies, and the rate of rate and dose errors. Event reports will be tracked as a secondary measure, recognizing their limits. Nurse time spent programming pumps will be measured in a small time study, since a benefit to nurses would support adoption.

Recommendation

The recommendation has two steps. First, align the drug library with pharmacy's stocked concentrations within three months and measure library compliance. Second, if library compliance improves but rate and dose discrepancies remain above 5% in a repeat audit, proceed with pump interoperability through the system's existing record and pump vendors, with a pilot on two units.

Conclusion

Starting with the organization's own data shows that intravenous errors are concentrated at the pump and that library bypass is common. Considering classes of technology before products, keeping vendor claims separate, and asking whether technology is needed leads to a staged recommendation: fix the library first, then add interoperability if the data still justify it.

5

References

Institute for Safe Medication Practices. (2020). Guidelines for optimizing safe implementation and use of smart infusion pumps. Institute for Safe Medication Practices.

Schnock, K. O., Dykes, P. C., Albert, J., Ariosto, D., Call, R., Cameron, C., Carroll, D. L., Drucker, A. G., Fang, L., Garcia-Palm, C. A., Husch, M. M., Maddox, R. R., McDonald, N., McGuire, J., Rafie, S., Robertson, E., Saine, D., Sawyer, M. D., Smith, L. P., ... Bates, D. W. (2017). The frequency of intravenous medication administration errors related to smart infusion pumps: A multihospital observational study. BMJ Quality & Safety, 26(2), 131-140. https://doi.org/10.1136/bmjqs-2015-004465

The Capella NURS FPX 8022 Assessment 1 instructions

The first assessment in NURS FPX 8022 asks you to use organizational data and evidence to recommend a technology solution for a practice problem. You analyze the problem with the organization's data, assess the data's quality, identify the class of technology that could help, review independent evidence separately from vendor claims, gather user perspectives, consider non-technology alternatives, compare options on cost and risk, and make a recommendation with success measures. Data can be real with permission or composite. The recommendation may be that technology is not the answer. Scholarly evidence and safety organization reports, such as ISMP, support the analysis.

How the NURS-FPX8022 Assessment 1 example is put together

The paper follows the order a careful recommendation should take. It opens with the two hospitals' own intravenous medication error data, then examines how complete and reliable those reports are, since voluntary reporting undercounts. The class of technology comes next, smart pumps, pump interoperability or barcode scanning, before any product is named. Independent evidence is reviewed apart from vendor material, and nurses' own accounts of where errors happen are reported. A section asks directly whether technology is the answer, weighing process changes such as independent double checks. Costs and resources, risks of each path and measures of success follow, and the recommendation is drawn from all of them.

Where the marks sit in the NURS FPX 8022 Assessment 1 scoring guide

Seven rows make up the guide: the analysis of local data, its quality, the technology options, the evidence review, the user input, the alternatives and the recommendation. Analysis reaches Distinguished when the organization's own error numbers are central and broken down by where errors happen. Data quality scores higher when limits such as under-reporting in voluntary systems are named and their effect on the conclusion is explained. The options criterion rewards thinking in classes of technology before products, so the analysis is not captured by a vendor. Evidence earns credit when independent studies are kept separate from vendor claims and appraised. Considering non-technology alternatives, such as independent double checks, shows judgment. Recommendations should include success measures with baselines. Doctoral synthesis and APA accuracy apply.

NURS FPX 8022 Assessment 1 help from the desk

Students often start with a product and work backward to justify it. Another mistake is treating vendor white papers and case studies as evidence. Data quality is rarely examined, even though voluntary error reports undercount by a wide margin, which can hide the real size of the problem. User input is left out, though nurses usually know where the errors occur. Non-technology alternatives are ignored, which weakens the recommendation even when technology is the right answer. Costs are limited to purchase price, leaving out interfaces, training and maintenance. Success measures are vague, such as fewer errors, without a baseline or target. A model recommendation for your own problem can be prepared on request, free the first time.

Get a NURS FPX 8022 Assessment 1 example written to your instructions

Send the Assessment 1 instructions and the scoring guide from your NURS FPX 8022 courseroom, plus the operational data your own recommendation is built on. We write a custom example against those exact criteria and return it in 24 to 48 hours. The first custom sample is free, and a recommendation grown out of the organization's own numbers is what the title means by evidence-based. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.

More NURS FPX 8022 papers and DNP samples

NURS FPX 8022 Assessment 1 questions, answered

What data should I use for NURS FPX 8022 Assessment 1?

Your organization's own data on the problem the technology is meant to address, such as error reports, audits, or quality measures, with an honest look at their limits.

What does "class before product" mean?

Decide what kind of technology fits the problem, such as barcode scanning, smart pumps, or clinical decision support, before comparing specific vendors' products.

Can the recommendation be that technology is not the answer?

Yes. A strong paper asks whether process or staffing changes would address the problem better, and recommends technology only if it is the right tool.

Can the NURS FPX 8022 Assessment 1 recommendation be that technology is not the answer?

Yes. If the data and evidence show a process change would work as well or better, recommend it and explain why. The assessment rewards sound judgment, not a purchase.

Where can I find a free NURS FPX 8022 Assessment 1 sample paper?

This page contains the full IV medication error technology recommendation, with local data, data quality, technology classes, evidence, nurse input, alternatives and measures. A free custom recommendation is available.